The effects of early parenteral amino acids on sick premature infants

Ruth Heimler1, Janine M Bamberger, Ponthenkandath Sasidharan

  • 1Department of Pediatrics, Medical College of Wisconsin and the Children's Hospital of Wisconsin, Milwaukee, WI 53217, USA.

Indian Journal of Pediatrics
|September 11, 2010
PubMed

Insights

Early amino acid supplementation in premature infants did not affect body weight or fluid shifts. However, it led to higher serum urea levels and improved nitrogen balance, suggesting benefits for nutritional support.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Metabolic Research

Background:

  • Sick premature infants often require nutritional support to optimize growth and development.
  • Parenteral amino acid administration is a key component of nutritional management in neonates.
  • The optimal timing for initiating parenteral amino acids in sick premature infants remains an area of investigation.

Purpose of the Study:

  • To investigate the impact of early versus delayed parenteral amino acid administration on body weight, fluid balance, and metabolic parameters in sick premature infants during the first week of life.

Main Methods:

  • Randomized controlled trial comparing early (within 24 hours) versus delayed (day 4) parenteral amino acid administration in sick premature infants.
  • Measurements included body weight, total body water, extracellular water, intracellular volume change, plasma amino acid and ammonia levels, urea levels, and nitrogen balance.
  • Energy intake was standardized between groups.

Main Results:

  • No significant differences in body weight or intracellular volume change were observed between groups, despite differing protein intake.
  • Infants receiving early amino acids had significantly higher plasma urea levels compared to the delayed group.
  • Early amino acid administration resulted in positive nitrogen balance, while the delayed group showed negative nitrogen balance.

Conclusions:

  • Early parenteral amino acid administration does not significantly impact body weight or fluid distribution in sick premature infants.
  • Higher serum urea concentrations are associated with early amino acid administration.
  • Delayed amino acid provision led to negative nitrogen balance, highlighting the importance of timely nutritional support.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...